Bertomeu-González V, Anguita M, Moreno-Arribas J, Cequier A, Muñiz J, Castillo-Castillo J, Sanchis J, Roldán I, Marín F, Bertomeu-Martínez V
Clin Cardiol. 2015 Jun;38(6):357-64, PMID: 25962838
Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control in patients under VKA treatment in the prevention of stroke for atrial fibrillation (AF).
CARDIAC & CARDIOVASCULAR SYSTEMS